Vimalanand S. Prabhu, M.Mgmt, Ph.D.

Associate Principal Scientist
Merck
Health Economic Statistics
One Merck Drive
Whitehouse Station, NJ
USA 08889
Email: vimalanand.prabhu@merck.com

Papers:

COST-EFFECTIVENESS OF METFORMIN + SITAGLIPTIN COMPARED TO METFORMIN + SULPHONYLUREA IN SWEDEN: ADJUSTING THE UNITED KINGDOM PROSPECTIVE DIABETES STUDIES (UKPDS) EQUATIONS FOR INCREASED SULPHONYLUREA DRUG-INDUCED CARDIOVASCULAR RISKS